The share of corresponding or leading authors in scientific publications in drug discovery in Canada is projected to steadily decline from 2024 to 2028. Starting at 84.09% in 2024, it is forecasted to decrease to 82.32% by 2028. Prior estimates place the 2023 figure slightly higher, reflecting an ongoing trend of diminishing individual leadership in these publications. This decline represents a subtle but consistent negative year-on-year change.
Future trends to watch for include:
- Collaborative authorship models may continue to rise, influencing corresponding author shares.
- The increasing emphasis on interdisciplinary research might redistribute authorship roles.
- Technological advances in drug discovery could alter publication dynamics, affecting author roles.
